Companies · MOS · Chemical (Specialty)
What does Mosaic's price assume?
The margin the price assumes
Revenue grows as its record suggests; the operating margin is solved at today's price.
At $22.80 on November 11, 2026, with growth of 3.1% a year, the price assumes an operating margin of 11.3% by year 5.
The price assumes
11.3%
Operating margin by year 5, solved at the price
Its 10-year median
6.8%
Fiscal 2016–2025, adjusted for R&D and leases
Its industry
12.5%
Chemical (Specialty), Damodaran Online, January 2026
The price assumes a margin above the company's own median, and below its industry's.
The numbers behind the chart
| Fiscal year | Adjusted operating margin |
|---|---|
| 2016 | 4.5% |
| 2017 | 6.3% |
| 2018 | 12.5% |
| 2019 | −11.6% |
| 2020 | 5.4% |
| 2021 | 20.4% |
| 2022 | 25.3% |
| 2023 | 10.1% |
| 2024 | 6.0% |
| 2025 | 7.3% |
- Revenue growth, years 1 to 5
- 3.1% a yearFrom its own revenue growth, the lower of its 5- and 10-year rates (here the 10-year).SEC filings, revenue to fiscal 2025
- Margin path
- From today's margin to 11.3% by year 5Solved at the price. After that, the margin holds.
The growth the price assumes
At its median margin, no revenue growth between −50% and 100% a year matches today's price.
The assumptions both views share
These are neutral settings, the same for every company. Each view holds them and solves for one driver at today's price.
- Reinvestment
- $1.11 of revenue for each $1 investedThe industry's sales-to-capital ratio: how much new capital growth needs.Damodaran Online, January 2026 industry data, Chemical (Specialty)
- Cost of capital
- 7.40%The return investors need for the risk: the industry's beta, the market's risk premium, and debt rated Baa2/BBB from its median margin, with a stated 5-year debt maturity. Built by the engine from the parts listed under Sources, each with its date.
- After year 10
- Growth at the riskfree rate, foreverNew investment earns its cost of capital and no more, so growth after year 10 adds no value, and the cost of capital moves to a mature company's.
This is a mechanical starting point with neutral assumptions, not a valuation. The story decides.
Want to run your own story for Mosaic?
Join the waitlistSources
- Price: Qualuation's records, close of November 11, 2026.
- 10-K for the period ended December 31, 2025, filed February 27, 2026 (SEC EDGAR, accession 0001285785-26-000017).
- 10-Q for the period ended June 30, 2026, filed August 5, 2026 (SEC EDGAR, accession 0001285785-26-000112).
- Margin record: SEC filings, fiscal 2016-2025, operating margin adjusted for R&D and leases.
- Industry margin: Damodaran Online, January 2026 industry data, Chemical (Specialty), adjusted for R&D and leases.
- Sales to capital: Damodaran Online, January 2026 industry data, Chemical (Specialty).
- US 10-year Treasury yield (FRED), October 29, 2026.
- Less the US default spread (Damodaran Online, July 2026).
- Industry beta, Chemical (Specialty) (Damodaran Online, January 2026).
- Equity risk premium (Damodaran Online, October 2026).
- Debt rated Baa2/BBB at its median margin (rating table, Damodaran Online, January 2026).
- The margin the price assumes: solved by the engine at the price on November 12, 2026, with the assumptions above.